138 related articles for article (PubMed ID: 20010384)
1. Role of the oxygen-dependent degradation domain in a hypoxia-inducible gene expression system in vascular endothelial growth factor gene therapy.
Jin H; Liu ML; Kim HA; Lee M; An S; Oh J; Cho J; Yi S; Kim K; Yoon D; Ha Y
Spine (Phila Pa 1976); 2009 Dec; 34(26):E952-8. PubMed ID: 20010384
[TBL] [Abstract][Full Text] [Related]
2. Neural stem cells modified by a hypoxia-inducible VEGF gene expression system improve cell viability under hypoxic conditions and spinal cord injury.
Lian Jin H; Pennant WA; Hyung Lee M; Su S; Ah Kim H; Lu Liu M; Soo Oh J; Cho J; Nyun Kim K; Heum Yoon D; Ha Y
Spine (Phila Pa 1976); 2011 May; 36(11):857-64. PubMed ID: 21192293
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia-inducible expression of vascular endothelial growth factor for the treatment of spinal cord injury in a rat model.
Choi UH; Ha Y; Huang X; Park SR; Chung J; Hyun DK; Park H; Park HC; Kim SW; Lee M
J Neurosurg Spine; 2007 Jul; 7(1):54-60. PubMed ID: 17633488
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia-inducible gene expression system using the erythropoietin enhancer and 3'-untranslated region for the VEGF gene therapy.
Lee M; Choi D; Choi MJ; Jeong JH; Kim WJ; Oh S; Kim YH; Bull DA; Kim SW
J Control Release; 2006 Sep; 115(1):113-9. PubMed ID: 16962197
[TBL] [Abstract][Full Text] [Related]
5. A hypoxia-inducible gene expression system using erythropoietin 3' untranslated region for the gene therapy of rat spinal cord injury.
Choi BH; Ha Y; Ahn CH; Huang X; Kim JM; Park SR; Park H; Park HC; Kim SW; Lee M
Neurosci Lett; 2007 Jan; 412(2):118-22. PubMed ID: 17178192
[TBL] [Abstract][Full Text] [Related]
6. Ischemic injury-specific gene expression in the rat spinal cord injury model using hypoxia-inducible system.
Lee M; Lee ES; Kim YS; Choi BH; Park SR; Park HS; Park HC; Kim SW; Ha Y
Spine (Phila Pa 1976); 2005 Dec; 30(24):2729-34. PubMed ID: 16371895
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia-inducible vascular endothelial growth factor gene therapy using the oxygen-dependent degradation domain in myocardial ischemia.
Kim HA; Lim S; Moon HH; Kim SW; Hwang KC; Lee M; Kim SH; Choi D
Pharm Res; 2010 Oct; 27(10):2075-84. PubMed ID: 20607367
[TBL] [Abstract][Full Text] [Related]
8. Controlled nonviral gene delivery and expression using stable neural stem cell line transfected with a hypoxia-inducible gene expression system.
Liu ML; Oh JS; An SS; Pennant WA; Kim HJ; Gwak SJ; Yoon DH; Kim KN; Lee M; Ha Y
J Gene Med; 2010 Dec; 12(12):990-1001. PubMed ID: 21157823
[TBL] [Abstract][Full Text] [Related]
9. The experimental study of hypoxia-inducible factor-1alpha and its target genes in spinal cord injury.
Xiaowei H; Ninghui Z; Wei X; Yiping T; Linfeng X
Spinal Cord; 2006 Jan; 44(1):35-43. PubMed ID: 16044166
[TBL] [Abstract][Full Text] [Related]
10. Augmentation of erythropoietin enhancer-mediated hypoxia-inducible gene expression by co-transfection of a plasmid encoding hypoxia-inducible factor 1alpha for ischemic tissue targeting gene therapy.
Lee S; Kim K; Kim HA; Kim SW; Lee M
J Drug Target; 2008 Jan; 16(1):43-50. PubMed ID: 18172819
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia as a target for tissue specific gene therapy.
Rhim T; Lee DY; Lee M
J Control Release; 2013 Dec; 172(2):484-94. PubMed ID: 23742881
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia-inducible VEGF gene delivery to ischemic myocardium using water-soluble lipopolymer.
Lee M; Rentz J; Bikram M; Han S; Bull DA; Kim SW
Gene Ther; 2003 Sep; 10(18):1535-42. PubMed ID: 12907944
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional and post-translational regulatory system for hypoxia specific gene expression using the erythropoietin enhancer and the oxygen-dependent degradation domain.
Kim HA; Kim K; Kim SW; Lee M
J Control Release; 2007 Aug; 121(3):218-24. PubMed ID: 17628167
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-regulated expression of attenuated diphtheria toxin A fused with hypoxia-inducible factor-1alpha oxygen-dependent degradation domain preferentially induces apoptosis of hypoxic cells in solid tumor.
Koshikawa N; Takenaga K
Cancer Res; 2005 Dec; 65(24):11622-30. PubMed ID: 16357173
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia-induced expression of VEGF in the organotypic spinal cord slice culture.
An SS; Pennant WA; Ha Y; Oh JS; Kim HJ; Gwak SJ; Yoon DH; Kim KN
Neuroreport; 2011 Jan; 22(2):55-60. PubMed ID: 21753742
[TBL] [Abstract][Full Text] [Related]
16. Hyperbaric oxygen intervention on expression of hypoxia-inducible factor-1α and vascular endothelial growth factor in spinal cord injury models in rats.
Zhou Y; Liu XH; Qu SD; Yang J; Wang ZW; Gao CJ; Su QJ
Chin Med J (Engl); 2013 Oct; 126(20):3897-903. PubMed ID: 24157153
[TBL] [Abstract][Full Text] [Related]
17. Gene therapy of neural cell injuries in vitro using the hypoxia-inducible GM-CSF expression plasmids and water-soluble lipopolymer (WSLP).
Kim JM; Lee M; Kim KH; Ha Y; Choi JK; Park SR; Park H; Park HC; Ahn CH; Kim SW; Choi BH
J Control Release; 2009 Jan; 133(1):60-7. PubMed ID: 18938203
[TBL] [Abstract][Full Text] [Related]
18. Characterization of neural stem cells modified with hypoxia/neuron-specific VEGF expression system for spinal cord injury.
Yun Y; Oh J; Kim Y; Kim G; Lee M; Ha Y
Gene Ther; 2018 Jan; 25(1):27-38. PubMed ID: 29155421
[TBL] [Abstract][Full Text] [Related]
19. Post-translational regulation of gene expression using the ATF4 oxygen-dependent degradation domain for hypoxia-specific gene therapy.
Cho SH; Oh B; Kim HA; Park JH; Lee M
J Drug Target; 2013 Nov; 21(9):830-6. PubMed ID: 23952904
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia-specific VEGF-expressing neural stem cells in spinal cord injury model.
Oh JS; An SS; Gwak SJ; Pennant WA; Kim KN; Yoon DH; Ha Y
Neuroreport; 2012 Feb; 23(3):174-8. PubMed ID: 22186804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
